These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8622082)

  • 1. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients.
    Stephens AW; Gonin R; Hutchins GD; Einhorn LH
    J Clin Oncol; 1996 May; 14(5):1637-41. PubMed ID: 8622082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
    Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
    Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling.
    Sugawara Y; Zasadny KR; Grossman HB; Francis IR; Clarke MF; Wahl RL
    Radiology; 1999 Apr; 211(1):249-56. PubMed ID: 10189480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
    Spermon JR; De Geus-Oei LF; Kiemeney LA; Witjes JA; Oyen WJ
    BJU Int; 2002 Apr; 89(6):549-56. PubMed ID: 11942962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary management of postchemotherapy testis cancer.
    Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
    Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
    Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Harper PG; Huddart RA
    Br J Cancer; 2000 Oct; 83(7):863-9. PubMed ID: 10970686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy.
    Johns Putra L; Lawrentschuk N; Ballok Z; Hannah A; Poon A; Tauro A; Davis ID; Hicks RJ; Bolton DM; Scott AM
    Urology; 2004 Dec; 64(6):1202-7. PubMed ID: 15596197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
    Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
    Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum.
    Vuky J; Bains M; Bacik J; Higgins G; Bajorin DF; Mazumdar M; Bosl GJ; Motzer RJ
    J Clin Oncol; 2001 Feb; 19(3):682-8. PubMed ID: 11157018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors.
    Hartmann JT; Rick O; Oechsle K; Kuczyk M; Gauler T; Schöffski P; Schleicher J; Mayer F; Teichmann R; Kanz L; Bokemeyer C
    Ann Surg; 2005 Aug; 242(2):260-6. PubMed ID: 16041217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies.
    Sheinfeld J
    Semin Urol Oncol; 2002 Nov; 20(4):262-71. PubMed ID: 12489059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of intrathoracic metastases of nonseminomatous germ cell tumors.
    Meyer CA; Conces DJ
    Chest Surg Clin N Am; 2002 Nov; 12(4):717-38. PubMed ID: 12471874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
    Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
    Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology.
    Stomper PC; Jochelson MS; Garnick MB; Richie JP
    AJR Am J Roentgenol; 1985 Oct; 145(4):743-6. PubMed ID: 3875994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up.
    Karapetis CS; Strickland AH; Yip D; Steer C; Harper PG
    Intern Med J; 2003; 33(9-10):427-35. PubMed ID: 14511195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery.
    Kesler KA; Rieger KM; Ganjoo KN; Sharma M; Fineberg NS; Einhorn LH; Brown JW
    J Thorac Cardiovasc Surg; 1999 Oct; 118(4):692-700. PubMed ID: 10504636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.
    De Santis M; Bokemeyer C; Becherer A; Stoiber F; Oechsle K; Kletter K; Dohmen BM; Dittrich C; Pont J
    J Clin Oncol; 2001 Sep; 19(17):3740-4. PubMed ID: 11533096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse.
    Sanchez D; Zudaire JJ; Fernandez JM; Lopez J; Arocena J; Sanz G; Gimenez M; Rosell D; Robles JE; Berian JM
    BJU Int; 2002 Jun; 89(9):912-6. PubMed ID: 12010239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
    Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.